In the last years it has been shown that many components of tumor microenvironment (tM) can induce cell signaling that permit to breast cancer cells (BC) to maintain their aggressiveness. Ion channels have a role in mediating tM signal; recently we have demonstrated a functional collaboration between Kv10.1 and Orai1 channels in mediating the pro-survival effect of collagen 1 on BC cells. Here we show how SPCA2 (Secretory Pathway Ca 2+ ATPase) has a role in this process and is able to support survival and proliferation induced by collagen 1. By participating to an auto-sustaining loop, SPCA2 enhances membrane expression of Kv10.1 and Orai1; the activity of every component of this trio is necessary to mediate a store independent calcium entry (SICE). This SICE is fundamental to maintain both the activation of the pro-survival pathway and the membrane localization and consequently the activity of the two channels. Moreover, the three proteins and the collagen receptor DDR1 are overexpressed only in aggressive tumors tissues. In this work, we propose a novel association between SPCA2, Kv10.1 and Orai1 involved in mediating transduction signals from TM to the BC cells that can be potentially exploited in the search of novel therapeutic targets specific to tumor tissues.
Results
SPCA2, Kv10.1, Orai1 and DDR1 are highly expressed in breast cancer tissues. We recently demonstrated that Kv10.1 and Orai1 are involved in the regulation of collagen-induced survival of the BC cell line MCF-7. In addition, we observed that this process was closely related to the expression of the collagen-specific receptor DDR1 16 . Indeed, it was reported that collagen is a crucial component of the TM of BC specifically in the promotion of tumor initiation and progression 21 . In our study, collagen 1 was used to mimic the TM of BC cells. We thus decided to perform immunohistochemistry experiments to investigate the expression of the partners in 29 BC samples. Using serial sections, we observed that all of the specimens show staining for all the three partners previously described in cancerous areas (Kv10.1, Orai1 and DDR1; Fig. 1 ). The intensities of staining are high in cancerous compared to control tissues (Fig. 1B) . Moreover, we also analyzed the expression of SPCA2 in consecutive serial sections and we observed its overexpression in the same BC samples compared to healthy ones; this expression was detected in the same areas of consecutive slices as Kv10.1, Orai1 and DDR1.
SPCA2, as Kv10.1 and Orai1, participates to collagen 1 mediated survival in BC cells. Since it was known that in BC cells SPCA2 is able to regulate Orai1 activity, we wanted to investigate whether SPCA2 has a role even in the collagen 1 induced survival mediated by Orai1 and Kv10.1. We studied apoptosis rate after 48 hours of starvation in cells seeded or not on collagen 1. Figure 2A showed that the apoptosis resistance acquired after collagen treatment is lost when SPCA2 is silenced in MCF-7 cells (apoptotic rate (%) siCtl −Coll 12.45 ± 0.45, +Coll 6.95 ± 0.45; siSPCA2 −Coll 14.55 ± 0.25, +Coll 14.55 ± 2.15) as it was demonstrated for Kv10.1 and Orai1. In addition, we analyzed cells mortality in the same conditions with a Trypan Blue assay and we observed the same percentage of loss of collagen 1 pro-survival effect in siSPCA2 MCF-7 cells (Fig. 2B ). Moreover, we observed the same effect when we silenced at the same time SPCA2 and Kv10.1 (Fig. 2Ba , Tables 1 and 2 for values) or SPCA2 and Orai1 ( Fig. 2Bb ) suggesting that all the three proteins participate in the same collagen 1-induced pathway. Moreover, SPCA2 expression seemed not affected by collagen ( Supplementary Fig. 1Aa ,b), in contrast Orai1 and Kv10.1 expression is increased in the same condition 16 . Supplementary Fig. 1B ,C showed the efficiency of transfection with siRNA against Kv10.1, Orai1 and SPCA2. Furthermore, to confirm the role of SPCA2 in collagen 1 mediated survival, we showed that in siSPCA2 cells there is no more pERK1/2 activation, typical of collagen treated BC cells ( Supplementary Fig. 1D ).
Kv10.1, SPCA2 and Orai1 regulate a basal calcium entry in MCF-7 cells in response of collagen 1 coating.
In 2010, the work of Feng and collaborators allowed to understand the mechanism of basal activation of Orai1 channels through its coupling with SPCA2 18 . In addition, we have demonstrated recently that collagen 1 increases the calcium entry that is regulated mainly by the cooperation of both channels Kv10.1 and Orai1 16 . We then examined the basal calcium entry in MCF-7 cells and the possible involvement of the SPCA2 protein in the collagen-dependent calcium entry 48 h post-starvation. Moreover, we evaluated whether the calcium influx activated in response to collagen 1 treatment was independent from Ca 2+ stocks' depletion and its regulation by the three proteins. First, we observed that the fluorescence ratio, in the presence of the normal extracellular medium (2 mM Ca 2+ ), was significantly higher in siCtl MCF-7 cells seeded on collagen 1 compared to other conditions ( Fig. 3Ab ,Ca, − Coll siCtl 0.85 ± 0.01, +Coll siCtl 1.06 ± 0.02). Moreover, siCtl MCF-7 treated with collagen 1 showed a very significant decrease in the fluorescence ratio during the perfusion of the 0 mM Ca 2+ extracellular medium in contrast to cells not treated with collagen seeded on plastic indicating a greater basal calcium entry induced in the presence of collagen 1 (Fig. 3Ab ); this effect was abolished when SPCA2, Kv10.1 or Orai1 were silenced ( Fig. 3A ,Ca, siCtl −0.17 ± 0.03, siSPCA2−0.01 ± 0.04, siKv10.1−0.001 ± 0.03, siOrai1−0.03 ± 0.02). We obtained the same profiles evaluating Ca 2+ entry with Mn 2+ quench protocols ( Fig. 3B ,Cb). Moreover, with this protocol, we observed that there was no additive effect after the double silencing of SPCA2-Kv10.1 or SPCA2-Orai1 ( Fig. 3B ,Cb, +Coll siCtl −0.78 ± 0.11, siSPCA2−0.3 ± 0.11, siKv10.1−0.28 ± 0.01, siOrai1−0.26 ± 0.02, siSPCA2-Kv10.1−0.28 ± 0.01, siSPCA2-Orai1−0.36 ± 0.03). The recording of basal Ca 2+ currents with patch clamp experiments confirm the inhibition of the currents stimulated by collagen 1 treatment in siSPCA2, siKV10.1, siOrai1 MCF-7 cells and also in siSPCA2-Kv10.1 and siSPCA2-Orai1 cells ( Fig. 3Da ,b, average current density values at −100 mV: siCtl −3.99 ± 0.24 pA/pF, siOrai1−2.45 ± 0.45 pA/pF, siKv10.1−2.06 ± 0.28 pA/pF, siSPCA2−2.88 ± 0.33 pA/pF, siS-PCA2-Orai1−2.13 ± 0.32 pA/pF, siSPCA2-Kv10.1−1.87 ± 0.23 pA/pF). Finally, we verified the effect of collagen 1 on SOCE using specific protocols for Ca 2+ imaging ( Supplementary Fig. 2A ), and patch clamp ( Supplementary  Fig. 2B ). From these experiments, neither collagen nor siKv10.1, Orai1 and SPCA2 affected SOCE. Moreover, siStim1 transfected cells were used as a control of SOC entry inhibition (Supplementary Fig. 2A ). All these results suggest that collagen 1 induced a basal calcium entry independently of the reticular calcium release through the participation of the three actors: Kv10.1, Orai1 and SPCA2.
SPCA2, in response to collagen 1, co-localizes and interacts with Kv10.1 and Orai1. To verify
whether, in addition to its participation to the same calcium pathway, SPCA2 was also co-localized with the two channels, we first carried out immunoprecipitation experiments with an anti-SPCA2 antibody. As shown in Fig. 4A , MCF-7 cells, when seeded on collagen 1 coating, show an increased physical interaction of SPCA2 with both Kv10.1 and Orai1 after 48 hours of starvation. Furthermore, treatment of cells with MβCD, which leads to cholesterol depletion and disruption of lipid raft microdomains, decreased collagen-induced interaction between SPCA2 and Kv10.1 or Orai1. This suggests that the interaction takes place at the level of lipid rafts (Fig. 4A ). In addition to this, Kv10.1 immunoprecipitation showed that the interaction between Kv10.1 and Orai1 is decreased when SPCA2 is silenced ( Supplementary Fig. 3 ). We then confirmed these data by using immunofluorescence-staining experiments (Fig. 4B ). This increase in the co-localization was significant when analyzed by the Manders Overlap Coefficient ( Table 2 . SPCA2, Orai1 and SPCA2 + Orai1 silencing inhibit the collagen 1-induced cell survival. SPCA2 regulates the membrane enrichment of Kv10.1 and Orai1 and Kv10.1 activity. We have previously shown that collagen 1 induces Kv10.1 and Orai1 overexpression 16 . Since now we found that the inhibition of SPCA2 expression completely reduced the collagen 1 effect, we first studied the effect of SPCA2 silencing on the collagen 1-induced overexpression of Kv10.1 and Orai1. We performed western blot experiments to monitor the protein levels of Kv10.1 and Orai1. As shown in Fig. 5A in siSPCA2 cells, the expression of both the proteins is reduced. It is known that SPCA2 interacts with Orai1 and regulates its trafficking 19 . Then, by using biotinylation assays we demonstrated that collagen 1 induces enrichment in membrane fractions of both Kv10.1 and Orai1. This increase is counteracted by the silencing of SPCA2 (Fig. 5B ).
We previously demonstrated that in our cell culture conditions, the most important contribution of the potassium conductance was due to Kv10.1 channel in MCF-7 cells 16 . In agreement with the impact of SPCA2 on the expression of Kv10.1 and Orai1 and the importance of Kv10.1 activity in MCF-7 cells, we observed that when SPCA2 is silenced there is a decrease in Kv10.1 channel activity represented by a low current density in patch clamp recordings ( Fig. 5C , average current density values at +100 mV siCtl 66.65 ± 17 pA/pF, siSPCA2 26.55 ± 4.76 pA/pF).
Ca 2+ levels and membrane protein enrichment participate in an auto-sustaining loop. We investigated whether the collagen 1-induced increase in membrane expression of Kv10.1 and Orai1 was sustained by the calcium entry. To monitor this, we checked if the membrane fractions of the channels were modulated by changes in calcium levels. In Fig. 6A we show that when cells are treated during the starvation period with EGTA at a concentration of 1.6 mM (predicted free external [Ca 2+ ] = 0.2 mM), the collagen 1-induced enrichment in membrane fraction of both the channels was decreased. Since all the data point to a tendency to a mutual regulation of the three components, we analyzed the effect of Orai1 silencing on Kv10.1. Figure 6B shows that the expression of Kv10.1 in membrane fractions of MCF-7 cells seeded on collagen 1 is decreased when Orai1 expression is impaired by siRNA. In addition, patch clamp measurements of potassium current densities in siOrai1 MCF-7 cells are significantly lower than those observed in siCtl cells ( Fig. 6C , average current density values at +100 mV siOrai1 17.95 ± 10.72 pA/pF).
Kv10.1 but not Orai1 trafficking through the Golgi apparatus is regulated by collagen 1 and SPCA2.
Since SPCA2 is a Golgi resident Ca 2+ ATPase, we decided to verify if the Golgi trafficking of the two channels to the membrane was influenced by collagen 1 and/or regulated by SPCA2. In order to achieve this, we performed immunofluorescence analysis of Kv10.1 and Orai1 in MCF-7 cells treated with the cell light Golgi-GFP at the moment of the starvation. In Fig. 7 we show staining for Kv10.1 (red), the Golgi (green) and the cells nuclei with DAPI (blue). Orai1 does not show co-localization with the Golgi but only a membrane localization that is increased when cells were seeded on collagen 1 ( Supplementary Fig. 4 ). Regarding Kv10.1, we observed a marked co-localization of the channel with Golgi apparatus in absence of collagen 1. This co-localization is decreased when the cells are seeded on collagen 1. In this condition, the silencing of SPCA2 leads to a Kv10.1 localization pattern more similar to cells in the absence of collagen (closely related to the Golgi staining) ( Fig. 7 ). In addition, we observed a similar modification of the localization of Kv10.1 in human tissue. Indeed, normal tissue has a reduced expression and a more colocalized pattern of Kv10.1 with trans-Golgi network compared to the tumor tissue ( Supplementary Fig. 7 ).
Discussion
Mammary gland represents an organ where the stroma plays a very important role in its development. Although BC is the second most commonly diagnosed cancer in the world only in recent years studies on the role of the TM in development of this cancer have been published. Indeed, it has been shown that many TM components can regulate tumor progression 22 .
In this work we deeply investigate the cellular mechanisms mediating the pro-survival effect of collagen 1, the most abundant matrix protein in breast 23 , which is correlated with a higher risk of BC development, especially in relation to its density 24 . We demonstrate for the first time a role for SPCA2 in this process. This happens through SPCA2 regulation of the localization and the activity of Kv10.1 and Orai1, mediating a store-independent calcium influx able to sustain channels membrane localization and activity and to promote cells survival.
Here we show for the first time at tissue level, the presence of all these three proteins in the same areas of aggressive breast tumors. A fourth protein also overexpressed in the very same areas is DDR1, the collagen 1 receptor who mediates its pro-survival effect in BC cells (Fig. 1) . In non-tumor sections these proteins are either not expressed (DDR1 and SPCA2) or faintly expressed (Orai1 and Kv10.1), suggesting the importance of their simultaneous expression to sustain the aggressiveness and the resistance of the tumor.
At a cellular level, we demonstrate here that SPCA2 acts in the pro-survival pathway activated by collagen 1 and that the pathway is common with Kv10.1 and Orai1 (Fig. 2, Supplementary Fig. 1 ). In this collagen mediated survival process, the three proteins act collectively to activate a basal calcium influx independently from SOC pathways. In fact when at least one of the three elements is silenced, the basal calcium influx is suppressed ( Fig. 3 , Supplementary Fig. 2 ). These results are in agreement with previous works that have associated the Orai1 channel with SOCE in ER − BC cells, and with SICE in ER + BC cells (MCF-7 and T-47D) 18, 25 . SPCA2 has already been reported to be able to interact with and regulate Orai1 activating SICE 18, 19 ; we now propose this mechanism as reported as mean ± SEM. (b) Histograms representing the averages ± standard error of currents values at −100 mV. siKV10.1 (n = 6); siCtl and siSPCA2-Kv10.1 (n = 5); siOrai1 and siSPCA2 (n = 4); siSPCA2-Orai1 (n = 3); *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA followed by Tukey post hoc tests.
Scientific RepoRts | (2019) 9:1175 | https://doi.org/10.1038/s41598-018-37602-7 a part of the BC cells response to TM stimulation and we add Kv10.1 as the third actor in this machinery. Both Kv10.1 and Orai1 co-localize with SPCA2 and physically interact with it. We demonstrated here that these interactions could take place at plasma membrane level or very close to it with some interactions of the Golgi apparatus network (Figs 4, 7 and Supplementary Figs 5 and 6 ). The different but very close situation of the partners in the plasma membrane and in the vesicle compartment of Golgi apparatus could also explain the low value of Manders Overlap Coefficient. In addition, we observed modifications of the localization of Kv10.1 in normal and cancerous human tissue ( Supplementary Fig. 7 ). Remarkably, this interaction seems dependent on the stability of lipid rafts (Fig. 4) . While SPCA2 expression do not change in response to collagen ( Supplementary Fig. 1 ), here we observed that its presence is fundamental for the increase of Kv10.1 and Orai1 expression when cells are seeded on collagen 1. Very interestingly, not only the expression of Kv10.1 and Orai1 are increased in response to collagen 1 but especially their membrane trafficking; moreover, the membrane localization of both the channels relies on the presence of SPCA2. Furthermore, the silencing of SPCA2 when cells are seeded on collagen 1 not only affects the membrane localization of both channels but also their activity (Fig. 5) . The impact of TM on the localization of ion channels in cancer is poorly explored. Indeed, until now only two studies described this process; the first demonstrated that a pro-domain of MMP-23 is able to induce an intra-cytoplasmic localization of Kv1.3 26 , whereas Tenascin-C, a glycoprotein expressed in the TM of various tissues, is able to increase the membrane localization of Nav sodium channels in neurons 27 . Our study demonstrates that, in response to collagen 1 stimuli in BC highly proliferating cells, the SPCA2-Kv10.1-Orai1 trio is co-localized at a membrane level. Triggered by the interaction with SPCA2, the membrane fractions and the activity of the two channels are boosted, sustaining a store-independent calcium entry. The K + efflux mediated by Kv10.1 is probably needed as shown in MDA-MB231 cells to shift the membrane potential towards negative values therefore increasing the driving-force for Ca 2+ 15 . In this case, hampering the activity of one of the three will lead to the loss of the collagen 1-induced pro-survival effect.
We have previously shown that in the collagen 1-induced pro-survival pathway there is a loop between the two channels expression and ERK phosphorylation, specifically connected to an increase in calcium entry 16 . Here, we reveal another part of the loop involving Ca 2+ levels. As the matter of fact the membrane fraction of both Kv10.1 and Orai1 is reduced when external Ca 2+ , and consequently Ca 2+ influx, is reduced. Thus, the calcium influx mediated by Orai1 is necessary also to maintain the membrane localization of both Orai1 and Kv10.1 (Fig. 6) . A Ca 2+ regulation of ion channels membrane insertion has already been shown by Cheng and colleagues; Ca 2+ entry via Orai1/STIM1-CRAC channel triggers plasma membrane insertion of TRPC1. After its membrane insertion and the interaction with STIM1, Ca 2+ entry mediated by TRPC1 is the primary regulator of KCa channel 28 .
According to the all provided data, we can hypothesize that in our system there should be a regulation by SPCA2 and Ca 2+ levels on the protein-trafficking pathways to the plasma membrane. Calcium has also a role in the regulation of some intracellular membrane fusion processes and consequently in protein trafficking. As an example, an important role has been reported for Ca 2+ in the trafficking from endoplasmic reticulum to the Golgi or during early endosome fusion 29 . Regarding the intra-Golgi trafficking there is a specific regulation of Ca 2+ concentration. Indeed, it is required in a narrow concentration range for this process 30 .
It is well known that Orai1 regulation by SPCA2 is independent from SPCA2 Golgi activity 18, 20 . In our work, we confirm that there is no localization of Orai1 in the Golgi apparatus either in cells seeded or not on collagen 1 (Supplementary Fig. 4) . Thus, the Ca 2+ regulation of Orai1 trafficking passes through an unknown Golgi-independent pathway. To address this question requires a full separate study.
Kv10.1 is one of the proteins that are processed in the Golgi for post-translational modification, notably glycosylation. This modification has an impact on both the protein trafficking and its functional properties as a channel 31 . Here we observed that Kv10.1 is less retained in the Golgi when cells are seeded on collagen 1 and in the presence of SPCA2 (Fig. 7) . Thus, Kv10.1 trafficking relies on Golgi complex; the effect of SPCA2 on this trafficking could be either direct, connected to its Golgi Ca 2+ -ATPase function 32 , or indirectly associated to the effect on intracellular Ca 2+ concentration. Regarding the mechanisms involved in the Golgi sorting of Kv10.1, we can speculate on two different hypothesis that can be confirmed with further investigations. The first one involves the effect of Ca 2+ on membranes fusion at the Golgi level. Another possibility can be related to the role of calcium regulation of glycosylation process. Indeed, it has been demonstrated that the glycosylation of thyroglobulin can be affected by changing Ca 2+ concentration 33 . Moreover, the yeast Gdt1, a Golgi-localized calcium transporter, has been reported to be required for proper protein glycosylation 34 . In a similar scenario Kv10.1 glycosylation and consequently its sorting could be dependent on Ca 2+ concentration. In conclusion of our work, we propose a novel association between SPCA2, Kv10.1 and Orai1 involved in a signal transduction pathway mediated by TM in BC cells. The complex, through the membrane insertion and activity of the two channels sustained by the interaction with SPCA2, promotes a basal calcium influx. This influx on one hand promotes cells proliferation and survival and on the other hand auto-sustain the complex activity ( Fig. 8) . Thus, the complex constituted by these three components has a fundamental role in promoting the aggressiveness of malignant cells. Since we have observed that the three proteins, together with the collagen 1 receptor DDR1, are co-expressed in aggressive tumors tissues, targeting one or more than one of these four actors would represent an attractive therapeutic strategy in BC treatment. Indeed, in this scenario, the alteration of expression, localization or function of one of the components of this new partnership would lead to the disruption of the TM-induced pro-survival pathways specific of BC cells and consequently inhibit the tumor progression.
Materials and Methods
Cell culture and collagen 1 extraction and preparation. MCF-7 cells culture was conducted as previously described 16 . Collagen 1 has been extracted and prepared as previously described 16 . All the experiments are conducted on cells after 48 hours of starvation in medium depleted of FBS. Cells are seeded in complete medium in presence or absence of collagen 1 coating (2.5 µg/cm 2 ) and after 24 hours the starvation is induced with a switch to serum free-medium. Cell transfection and RNA interference. Transfection of cells was performed using nucleofection technology (Amaxa Biosystems, Lonza, Aubergenville, France) according to the protocol previously described 11 . Cells were transiently transfected with siRNA directed against Kv10.1 (Dharmacon Research, Chicago, IL), Orai1 (Dharmacon Research, Chicago, IL), SPCA2 (Kaneka Eurogentec S.A.,Seraing, Belgium) and Stim1 (Santa Cruz Biotechnology, Inc., Heidelberg, Germany), or with scrambled siRNA as a control (siCtl) (siGENOME Non-Targeting siRNA, Dharmacon Research, Chicago, IL), and used 72 h after transfection.
Cell mortality. The cell mortality was assessed by Trypan blue assay as previously described 16 .
Western blotting. Proteins were extracted, quantified and separated as previously described 16 . The primary antibodies used were: anti-Kv10.1 (1:200, Santa Cruz Biotechnology, Inc., Heidelberg, Germany), anti-Orai1 (1:200, Sigma Aldrich, Saint-Quentin-Fallavier, France), anti-SPCA2 (1:250, Santa Cruz Biotechnology, Inc.), anti-ERK1/2 (1:500, Cell Signaling Tech., Danvers, USA), anti-p-ERK1/2 Thr202/Tyr204 (1:500, Cell Signaling Tech.). GAPDH (1:1,000, Cell Signaling Tech.) antibody was used for loading control experiments. Detection and quantification were realized as previously described 16 .
Kv10.1, Orai1 and SPCA2 staining. MCF-7 cells were washed (1 mM MgCl 2 , 100 mM KCl and 20 mM HEPES at 37 °C), then fixed and permeabilized using 4% paraformaldehyde in PBS supplemented with 40 μg/ mL digitonin for 10 min. Before staining, cells were washed three times with PBS and non-specific sites were saturated for 45 min with 10% normal goat serum (NGS) at room temperature. The anti-Kv10.1 (Alomone Labs, Jerusalem, Israel) or anti-Orai 1 (ProSci Inc, CA, USA) antibodies were added at dilution of 1:100 for 1 hour and detected in a first step after a 3% NGS saturation with a biotinylated anti-goat secondary antibody (1:50, Jackson Patch clamp experiments. For electrophysiological analysis, patch clamp analysis were realized as previously described 16 .
Calcium imaging. Cellular calcium imaging was used to investigate the Store Independent Calcium Entry (SICE), the basal calcium entry and the Store Operated Calcium Entry (SOCE). Briefly, MCF-7 cells were seeded on glass coverslips in 35 mm petri-dishes at a density of 10*10 4 cells and starved for 48 h. Cells were loaded with Fura-2 AM at 3 μM in extracellular recording solution for 45 min at 37 °C (in mM): NaCl 145, KCl 5, CaCl 2 2, MgCl 2 2, HEPES 10, glucose 5 and pH adjusted to 7.4 (NaOH). Cells were washed twice and then excited at 340/380 nm with a monochromator (TILL ® Photonics, Munich, Germany) or 360 nm (the isosbestic point of Fura-2 AM) with regards to the Manganese quenching experiments. Finally, Fura-2 emission was recorded at 510 nm by a CCD camera coupled to a Zeiss inverted microscope (Carl Zeiss MicroImaging, LLC, Oberkochen, Germany). The SICE was analyzed by following the variation of the ratio F340/380 (which corresponds to the intracellular calcium basal concentration) only by changing the calcium concentrations of the extracellular medium through the perfusion of 2 mM Ca 2+ to calcium-free extracellular medium (0 mM Ca 2+ ). Concerning the SOCE, cells were perfused by thapsigargin at 1 μM in free calcium extracellular medium inducing reticular calcium release, the cells were then perfused by calcium-rich extracellular medium (10 mM Ca 2+ ). The Mn 2+ quenching experiments were performed as previously described 16 .
Apoptosis analysis.
To estimate the percentage of apoptotic cells, we studied cell surface phosphatidylserine exposure, an early marker of apoptotic cell death, by performing a PE Annexin V Apoptosis Detection Kit I staining (BD Biosciences Pharmingen, Le Pont de Claix, France) as described 16 .
Immunohistochemistry. The study was approved by the "Comité de Protection des Personnes Nord-Ouest II". Informed consent was obtained from each patient. All procedures were performed in accordance with the Helsinki Declaration of 1975, revised in 1983. Twenty-nine human breast ductal adenocarcinoma specimens were obtained from women having undergone operations at the Amiens hospital. Additionally, normal tissue (used in Supplementary Fig. 7 ) was obtained with non-opposition of research used consent. Clinicopathological parameters of patients can be found in Table 3 . Immunohistochemical studies were performed using the indirect immuno-peroxidase staining technique on the paraffin-embedded material with a Ventana Benchmark Ultra instrument (Ventana Medical Systems, Roche Diagnostics, Meylan, France) and a hematoxylin counterstain as previously described 37 . Briefly, after blocking the endogenous peroxidase by the I-View Inhibitor (Ventana), sections were stained with an anti-Kv10. Biotinylation assay. To evaluate the differences in the membrane expression of the protein we performed biotinylation assays as following. 5*10 5 cells are plated on a P60 Petri-dish. Cells are washed with cold PBS and incubated with 2 mg of Sulfo-NHS-SS-biotine (Thermo Fisher Scientific, Rockford, IL) 45 minutes at 4° with shaking. The reaction is stopped by wash with cold PBS + 10 mM glycine. Cells are scraped in RIPA buffer. Ten per cent of the extract is kept for total protein samples and the rest is incubated overnight at 4° with streptavidine agarose beads (Thermo Fisher Scientific, Rockford, IL) pre-washed with RIPA. Beads are washed 4 times with RIPA buffer. Proteins are eluted with 50 µl of Laemmli 2X and heating 60° for 30' . Proteins are separated by denaturing SDS-PAGE, transferred onto nitrocellulose membranes and incubated with specifics antibodies for western blot.
Immunofluorescence and Golgi staining. To evaluate the localization of our proteins relative to Golgi apparatus, cells were treated with cell light Golgi-GFP (Life Technologies, Eugene, OR; 5 μl/10000 cells) 48 hours before fixation, simultaneously of cells starvation. Cells were fixed with paraformaldehyde 4% for 20 minutes, permeabilized with triton 0.5% and blocked for 30 minutes with BSA 3%. The cells are then incubated overnight with primary antibodies (Kv10.1 1/50, Santa Cruz Biotechnology, Inc., Heidelberg, Germany; Orai1 1/200, Sigma Aldrich, Saint-Quentin-Fallavier, France; SPCA2 1/100, Santa Cruz Biotechnology, Inc., Heidelberg, Germany), washed with PBS, incubated 1 hour with secondary antibodies conjugated with fluorophores (anti-mouse Alexa 546, 1/200, Life Technologies, Eugene, OR; anti-rabbit Alexa 549, 1/200, Thermo Fisher Scientific, Rockford, IL) and counterstained with DAPI to visualize the nuclei. Analyses were performed on a LSM 780 confocal microscope (Carl Zeiss) and analyzed with ZEN 2012 software. For immunofluorescence assay on human tissue, samples were stained with anti-Kv10.1 (1/50, Alomone Labs, Jerusalem, Israel) and TGN46 (1/100, Thermofisher Scientific).
Statistical analysis.
Data are presented as mean ± SEM (standard error of mean), n refers to the number of cells, and N refers to the number of cell line passages. All the experiments were performed in triplicate in at least 3 different cell lines passage number. The mean values of two groups were compared by the Student's t-test or Mann-Whitney rank sum test, using Sigma-Stat 3.0 (Systat Software, Inc.), differences between the values were considered significant when p < 0.05. The p-values < 0.05, <0.01, and <0.001 are represented as *,**, and ***, respectively. Mean values of more than two groups were tested using one or two-way analysis of variance (ANOVA) followed by Tuckey or Holm-Sidak post hoc tests, differences between the values were considered significant when p < 0.05. The p-values < 0.05 are represented as*. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
